Gehring H, Hornberger C, Dibbelt L, Rothsigkeit A, Gerlach K, Schumacher J, Schmucker P
Department of Anesthesiology, Medical University, Lubeck, Germany.
Acta Anaesthesiol Scand. 2002 Sep;46(8):980-6. doi: 10.1034/j.1399-6576.2002.460809.x.
While point-of-care testing (POCT) is being used increasingly as a basis for deciding on perioperative erythrocyte transfusion, no valid standards currently exist concerning the accuracy of Hb concentration measurements. For clinical employment, however, the confidence limits (+/-2 SD) of these measurements should lie close to 5 g/l. The aim of the present study was to evaluate the accuracy and precision of point-of-care testing for blood hemoglobin concentration (cHb in g/l) measurements in critically ill patients.
Fifty blood samples from 50 postoperative patients requiring intensive care treatment were withdrawn from a cannula in the radial artery into a 2-ml heparinized syringe (containing wet sodium heparinate in the conus), in a 2-ml Monovette with 50 IE lithium heparinate, and into a 2.7-ml cuvette with 1.6 mg potassium EDTA/ml blood. The POCT battery consisted of two blood gas analyzers (ABLTM 625 and 725, Radiometer, Copenhagen), the HemoCue system (Mallinckrodt Medical, Germany), and an automated hematology analyzer (M-2000(R), Sysmex, Germany). The cyanmethemoglobin method served as the reference 'gold standard' procedure. The blood gas analyzer and HemoCue systems were tested using dry and wet heparinized blood samples.
Hemoglobin concentrations of the reference measurements ranged from 73.9 to 159.4 g/l. The automated hematology analyzer method did reveal a small but systematic deviation for higher cHb values. For the blood gas analyzer and HemoCue system procedures there was no systematic deviation of bias for either the first measurement or the averaged data. Bland & Altman analysis revealed a larger scattering for the wet heparinized samples.
The above-stated requirement for POCT systems, i.e. that the confidence limits should lie close to 5 g/l cHb, held true for the dry heparinized samples of the blood gas analyzer (1st measurement and mean of 2), the HemoCue system (mean of 3) and the automated hematology analyzer.
即时检验(POCT)越来越多地被用作围手术期红细胞输血决策的依据,但目前关于血红蛋白浓度测量的准确性尚无有效标准。然而,对于临床应用而言,这些测量的置信限(±2标准差)应接近5 g/l。本研究的目的是评估重症患者床旁检测血血红蛋白浓度(cHb,单位为g/l)测量的准确性和精密度。
从50例需要重症监护治疗的术后患者的桡动脉插管中采集50份血样,分别注入2 ml肝素化注射器(圆锥部含有湿的肝素钠)、含有50 IE肝素锂的2 ml Monovette以及含有1.6 mg乙二胺四乙酸钾/ml血液的2.7 ml比色管中。POCT检测设备包括两台血气分析仪(ABLTM 625和725,雷度米特公司,哥本哈根)、HemoCue系统(马利克若德特医疗公司,德国)以及一台自动血液分析仪(M-2000(R),希森美康公司,德国)。氰化高铁血红蛋白法作为参考“金标准”方法。使用干燥和湿的肝素化血样对血气分析仪和HemoCue系统进行检测。
参考测量的血红蛋白浓度范围为73.9至159.4 g/l。自动血液分析仪方法对于较高的cHb值确实显示出较小但系统性的偏差。对于血气分析仪和HemoCue系统方法,首次测量或平均数据均未出现偏差的系统性差异。Bland & Altman分析显示湿肝素化样本的离散度更大。
上述对POCT系统的要求,即置信限应接近5 g/l cHb,对于血气分析仪(首次测量和两次测量均值)、HemoCue系统(三次测量均值)以及自动血液分析仪的干燥肝素化样本是成立的。